COMMUNIQUÉS West-GlobeNewswire

Eyconis Announces Initiation of First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet Age-Related Macular Degeneration Patients
18/08/2026
First patients dosed in OVERTURE, a Phase 1b/2a study evaluating EYC-0305, a potential long-acting anti-VEGF therapy designed for six-month or longer dosing intervals via standard intravitreal injection Milestone marks [...]
MediBeacon Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology
18/08/2026
The MediBeacon ® TGFR™ System is a first-in-kind product for point-of-care kidney function assessment Winners will be announced at the 20th annual Prix Galien USA Awards Ceremony on October 29, 2026, at the American [...]
Board-Certified Vascular and Endovascular Surgeon Performs First Commercial Symvess® Implantation; Cites Bioengineered Blood Vessel as “Revolutionary Advancement”
18/08/2026
– Jeromy Brink, MD, Mayo Clinic–trained vascular surgeon in Phoenix, is the first surgeon in Arizona to implant Symvess, the first and only FDA-approved bioengineered human blood vessel – – Symvess is available off-the- [...]
Noom Appoints Jim Bugden Chief Financial Officer as Company Enters Next Phase of Growth
18/08/2026
Financial and operational leader with deep experience scaling high-growth technology companies joins Noom to support the company's continued expansion PRINCETON, N.J., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Noom , the [...]
CRNA Coach Amanda Kay Launches $5 Live Bootcamp as The Mindful CRNA Expands Support for Nurses Entering Anesthesia
18/08/2026
CHICAGO, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Amanda Kay, MSN, CRNA opens a live three-day CRNA Bootcamp in late August, adds two coaching portals for nurses already in school, and confirms a pilot program beginning [...]
SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million
18/08/2026
SciSparc Invests C$2.7 million and holds approximately 44.6% of NeuroThera’s issued and outstanding common shares following the financing TEL AVIV, Israel, Aug. 18, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC [...]
Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom
18/08/2026
Initial three-year term includes minimum annual license commitments PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. (“ Nanox”, or the “Company” NASDAQ: NNOX), a leader in innovative medical imaging technology [...]
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors
18/08/2026
SOUTH SAN FRANCISCO, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for PLN- [...]
Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India’s Nuclear Regulatory Authority for International Manufacturing Center
18/08/2026
Kennewick, WA, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy ™ (PRnT) for the treatment of cancerous tumors, today announced two [...]
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
18/08/2026
Avance Clinical to Lead Preparatory Activities for Multi-Center Investigation Across Australia MELBOURNE, Australia, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company [...]
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
18/08/2026
Multi-year agreement with Peak Medical expands UroShield commercialization across the United Kingdom and Republic of Ireland TYLER, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue” or the “ [...]
Polomar Health Services Reports Second-Quarter Revenue of $1.53 Million and Positive Net Income
18/08/2026
Commercial prescription fulfillment drives significant revenue growth, a 61.2% gross margin and improved operating cash flow PALM HARBOR, Fla., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Polomar Health Services, Inc. (OTCQB: [...]
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
18/08/2026
Peer-reviewed research points to the extracellular matrix, the framework that holds tissue together, as central to that work. More than a decade of research has gone into Conexeu’s CXU™ Platform Highlights Regenerative [...]
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
18/08/2026
Dr. Charuworn’s extensive immunology drug development experience will help accelerate the clinical development of Coultreon’s first-in-class SIK3 inhibitor COL-5671 Leuven, Belgium. August 18, 2026 . Coultreon Biopharma [...]
Cloud 9 Vets calls on the CMA to add at-home pet euthanasia to the new mandatory vet price list
18/08/2026
Research by the UK in-home veterinary provider found 67% of pet owners had no idea a vet could come to the house to put pets to sleep. Chichester, West Sussex, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Cloud 9 Vets, a national [...]
Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
18/08/2026
Marking a new approach to innovation in medical robotics, the new centre will bring advances from a leading surgical robotics research group to patients more quickly Smith+Nephew (LSE:SN, NYSE:SNN), the global medical [...]
Transactions in connection with share buy-back program
18/08/2026
Company announcement no. 31 - 26 18 August 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
18/08/2026
Total revenue increases by 14% to CHF 119 million Operating profit increases by 32% to CHF 32 million and net profit by 77% to CHF 28 million Fosmanogepix phase 3 program on track for data readout and regulatory [...]
Coloplast A/S - Interim Financial Report, 9M 2025/26
18/08/2026
Interim financial results, 9M 2025/26 1 October 2025 - 30 June 2026 Coloplast delivered Q3 organic growth of 6% and 5% EBIT growth 1 in constant currencies. Strong quarter in both Chronic Care ex. China and [...]

Pages